Biophysical and theoretical investigation of benzo[c]coumarin functionalized Schiff base with human serum albumin

Interaction mechanism of a cysteine protease inhibitor, odanacatib, with human serum albumin: In vitro and bioinformatics studies

Odanacatib (ODN) is a selective cathepsin K inhibitor that acts as an anti-resorptive agent to treat osteoporosis. ODN is also found effective in reducing the effect of severe periodontitis. The interaction between ODN and human serum albumin (HSA) was investigated using spectroscopic, microscopic, and in silico approaches to characterize their binding. The fluorescence intensity of HSA increased upon the addition of increasing concentrations of ODN accompanied by blueshift in the fluorescence spectrum, which suggested hydrophobic formation around the microenvironment of the fluorophores upon ODN binding. A moderate binding affinity was obtained for ODN-HSA binding, with binding constant (Ka) values of ∼104 M-1. Circular dichroism results suggested that the overall secondary and tertiary structures of HSA were both only slightly altered upon ODN binding. The surface morphology of HSA was also affected upon ODN binding, showing aggregate formation. Drug displacement and molecular docking results revealed that ODN preferably binds to site III in subdomain IB of HSA, while molecular dynamics simulations indicated formation of a stable protein complex when site III was occupied by ODN. The ODN-HSA complex was mainly stabilized by a combination of hydrogen bonding, hydrophobic interactions, and van der Waals forces. These findings provide additional information to understand the interaction mechanism of ODN in blood circulation and may help in future improvements on the adverse effects of ODN.

Multispectroscopic Studies on HSA Interaction, DFT Calculations, Molecular Docking, and Antimicrobial Activities of Imine‐ Functionalized Tris(hydroxymethyl)aminomethane Derivatives

Following recent work on new Tris hydroxymethyl aminomethane Schiff base derivatives were synthesized and characterized by using NMR (1H, 13C, and depth), FT‐IR, and Mass spectroscopy. The crystal structure of STB has been determined by X‐ray diffraction analysis. The binding interaction of the 3 chemically synthesized molecules with human serum albumin has been examined under the pH=7.40 through UV‐visible absorption and fluorescence spectroscopy analysis. The result obtained from the fluorescence experiment (1014) suggests a static mechanism of quenching. By utilizing fluorescence spectroscopy to determine the binding constant (Kb=106), it was determined which ligands have the highest affinity for HSA and that these ligands had changed the structure of HSA. Through hydrophobic interactions, the ligands bind to HSA on site I (subdomain II), according to thermodynamic parameters like enthalpy change (ΔHo), entropy change (ΔSo), and Gibbs free energy change (ΔGo). The result of 3D fluorescence spectra also showed that albumin conformational changes were brought on by these ligands. The results of the experiments were supported by DFT and molecular docking of ligands with HSA. Escherichia coli, Stap. aureus, Aspergillus niger, and Aspergillus flavus were tested for antimicrobial activity against the synthesized compounds respectively.